focus -WSS

focus

author：knowledge 2025-09-30 16:25:05 - browse：6551

ESMO signage in Madrid. — At ESMO 2023, antibody-drug conjugates were featured prominently. Andrew Joseph/STAT

MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting, a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.

The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the compounds from ADC specialist Daiichi Sankyo. GSK followed up with an ADC licensing announcement of its own (if a much smaller one). Multiple ADC studies were presented at the meeting’s top sessions. ADCs were, in short, the belle of the cancer research ball.

The thing is, ADCs are actually quite an old approach.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： The biotech scorecard for Q1: 17 stock

WSS

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

New weight loss drugs work. But how can they best be used?

A single drug, study failures leave Anavex with nothing but cash

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Ahead of JPM, here's who's profiting most in health care

Doctors in states that ban abortion can still help patients

hotspot

focus

knowledge

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Trump team launching legal defense fund to help pay legal bills

State Dept. review finds Biden bears some blame for Afghanistan failures

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

In Memoriam: Notable people who died in 2023

Russian and Belarusian players banned from a women's tennis tournament in Prague

Apple is now the first public company to be valued at $3 trillion

Adidas to release second batch of Yeezy sneakers after breakup with Ye

Hepatitis C has a cure — but many Americans still lack access to it

Europe is fastest

leisure time

The FDA must approve intranasal treatments for anaphylaxis

Judge orders hearing on Trump's motion to disqualify Fulton County DA

JPM: CVS says Medicare Advantage patients are impacting profits

Feng Zhang, Grail founder join forces on new gene editing startup

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Russian and Belarusian players banned from a women's tennis tournament in Prague

hotspot

explore

Wikipedia

hotspot